Plasma advanced glycation endproduct, methylglyoxal-derived hydroimidazolone is elevated in young, complication-free patients with Type 1 diabetes

International Diabetes Federation. Diabetes prevalence. http://www.idf.org/home/index.cfm?node=264## Accessed 12/18/2008, 2008. World Health Organization. Diabetes, fact sheet no.312. http://www.who.int/mediacentre/factsheets/fs312/en/print.html Accessed 10/2/2008, 2008. Misselwitz, 2002, Advanced glycation end products in children with chronic renal failure and type 1 diabetes, Pediatr. Nephrol., 17, 316, 10.1007/s00467-001-0815-9 Lieuw-A-Fa, 2004, Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction, Nephrol. Dial. Transplant., 19, 631, 10.1093/ndt/gfg619 Hwang, 2005, Clinical implications of N epsilon-(carboxymethyl)lysine, advanced glycation end product, in children and adolescents with type 1 diabetes, Diabetes Obes. Metab., 7, 263, 10.1111/j.1463-1326.2004.00398.x Dost, 2008, Arterial hypertension determined by ambulatory blood pressure profiles: contribution to microalbuminuria risk in a multicenter investigation in 2,105 children and adolescents with type 1 diabetes, Diabetes Care, 31, 720, 10.2337/dc07-0824 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N. Engl. J. Med., 329, 977, 10.1056/NEJM199309303291401 Monnier, 1999, Diabetes, 48, 870, 10.2337/diabetes.48.4.870 Karachalias, 2003, Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats, Biochem. Soc. Trans., 31, 1423, 10.1042/bst0311423 Fosmark DS, Berg JP, Jensen AB, et al. Increased retinopathy occurrence in type 1 diabetes patients with increased serum levels of the advanced glycation endproduct hydroimidazolone. Acta Ophthalmol in press [Electronic publication ahead of print]. doi:10.111/j.1755-3768.2008.01300x. Mostafa, 2007, Plasma protein advanced glycation end products, carboxymethyl cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with diabetes, Mol. Cell. Biochem., 302, 35, 10.1007/s11010-007-9422-9 Goh, 2008, Clinical review: the role of advanced glycation end products in progression and complications of diabetes, J. Clin. Endocrinol. Metab., 93, 1143, 10.1210/jc.2007-1817 Jia, 2006, Structural and functional changes in human insulin induced by methylglyoxal, FASEB J., 20, 1555, 10.1096/fj.05-5478fje Park, 2003, Identification of the binding site of methylglyoxal on glutathione peroxidase: methylglyoxal inhibits glutathione peroxidase activity via binding to glutathione binding sites arg 184 and 185, Free Radic. Res., 37, 205, 10.1080/1071576021000041005 Bidasee, 2003, Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels, Diabetes, 52, 1825, 10.2337/diabetes.52.7.1825 Ahmed, 2005, Peptide mapping of human serum albumin modified minimally by methylglyoxal in vitro and in vivo, Ann. N. Y. Acad. Sci., 1043260 Koide, 2002, Xaa-arg-gly triplets in the collagen triple helix are dominant binding sites for the molecular chaperone HSP47, J. Biol. Chem., 277, 6178, 10.1074/jbc.M106497200 Champe, 2005, Fibrous proteins, 43 Thornalley, 2003, Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry, Biochem. J., 375, 581, 10.1042/bj20030763 Pruess, 2003, The proteome analysis database: a tool for the in silico analysis of whole proteomes, Nucleic Acids Res., 31, 414, 10.1093/nar/gkg105 Fosmark, 2006, Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus, Metabolism, 55, 232, 10.1016/j.metabol.2005.08.017 Ahmed, 2002, Biochem. J., 364, 1, 10.1042/bj3640001 2003, Clinical practice guidelines for the prevention and management of diabetes in Canada, Can. J. Diabetes, 27, S1 Han, 2007, Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with type 1 diabetes, Mol. Cell. Biochem., 305, 123, 10.1007/s11010-007-9535-1 Ahmed, 2005, Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes, Diabetes Care, 28, 2465, 10.2337/diacare.28.10.2465 Koschinsky, 1997, Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy, Proc. Natl. Acad. Sci. U. S. A., 94, 6474, 10.1073/pnas.94.12.6474 Beisswenger, 1999, Metformin reduces systemic methylglyoxal levels in type 2 diabetes, Diabetes, 48, 198, 10.2337/diabetes.48.1.198 Mentink, 2006, Time course of specific AGEs during optimised glycaemic control in type 2 diabetes, Neth. J. Med., 64, 10 Likidlilid, 2007, Glutathione and glutathione peroxidase in type 1 diabetic patients, J. Med. Assoc. Thai., 90, 1759 Thornalley, 1993, The glyoxalase system in health and disease, Mol. Aspects Med., 14, 287, 10.1016/0098-2997(93)90002-U Brett, 1993, Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues, Am. J. Pathol., 143, 1699 Koka, 2006, Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications, Circulation, 113, 1353, 10.1161/CIRCULATIONAHA.105.575589 Mamputu, 2004, Signalling pathways involved in retinal endothelial cell proliferation induced by advanced glycation end products: inhibitory effect of gliclazide, Diabetes Obes. Metab., 6, 95, 10.1111/j.1462-8902.2004.00320.x Gu, 2006, Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes, Nephrol. Dial. Transplant., 21, 299, 10.1093/ndt/gfi210 Gao, 2008, AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice, Am. J. Physiol. Heart Circ. Physiol., 295, H491, 10.1152/ajpheart.00464.2008 Yeh, 2001, Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion, Diabetes, 50, 1495, 10.2337/diabetes.50.6.1495